Key result
eGFR <60 is linked to ~80% lower odds of newly detected type 2 diabetes.
Why the study?
The characteristics and associated factors differentiating newly detected type 2 diabetes mellitus from prediabetes among cardiovascular outpatients at Hanoi Heart Hospital needed to be described and identified.
What clinical, laboratory, and medication factors are associated with newly detected type 2 diabetes mellitus compared with prediabetes among cardiovascular outpatients?
Cross-Sectional (n=92)
No
What clinical, laboratory, and medication factors are associated with newly detected type 2 diabetes mellitus compared with prediabetes among cardiovascular outpatients?
Answers are grounded in this paper and cite their sources.
This study highlights the high burden of cardiovascular comorbidities among outpatients with newly detected dysglycemia and supports systematic glucose and HbA1c screening in high-risk cardiovascular outpatients, particularly those with low HDL-C.
Objective: To describe the characteristics of patients with prediabetes and newly detected type 2 diabetes mellitus, and to identify factors associated with newly detected type 2 diabetes (versus prediabetes) among outpatients at Hanoi Heart Hospital. Methods: A cross-sectional study with an analytical component was conducted among 92 cardiovascular outpatients with prediabetes or newly detected type 2 diabetes at Hanoi Heart Hospital from May 2025 to July 2026. Associated factors were examined using univariable and multivariable logistic regression. Results: Thirty-five patients (38.0%) had prediabetes and 57 (62.0%) had newly detected type 2 diabetes. The mean age was 63.97 ± 11.78 years, and 62.0% were male. HbA1c and random glucose levels were significantly higher in patients with newly detected diabetes. In the multivariable model (n=88), eGFR <60 mL/min/1.73 m² (aOR=0.20; 95% CI: 0.05–0.84) and calcium channel blocker (CCB) use for less than one year (aOR=0.07; 95% CI: 0.01–0.71; only 7 patients) were inversely associated with newly detected diabetes. HDL-C <0.9 mmol/L showed a positive but non-significant trend (aOR=7.80; 95% CI: 0.86–70.69; p=0.068). Conclusion: Among cardiovascular outpatients with dysglycemia, low HDL-C (as a trend), eGFR <60 mL/min/1.73 m² and CCB use for less than one year were associated with newly detected type 2 diabetes. These associations do not establish causality and should be confirmed in larger longitudinal studies. The findings support systematic glucose/HbA1c screening in at-risk cardiovascular patients.
No takes yet. Share an insight, caveat, or question.
Vu et al. (2026) conducted a cross-sectional in Cardiovascular outpatients with prediabetes or newly detected type 2 diabetes mellitus (n=92). eGFR <60 mL/min/1.73 m2 vs. eGFR >=60 mL/min/1.73 m2 was evaluated on Newly detected type 2 diabetes mellitus (versus prediabetes) (aOR 0.20, 95% CI 0.05-0.84, p=0.029). Among cardiovascular outpatients with dysglycemia, eGFR <60 mL/min/1.73 m2 (aOR 0.20) and CCB use <1 year (aOR 0.07) were inversely associated with newly detected type 2 diabetes versus prediabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: